Glycomimetic antagonists for both e- and p-selectins

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 15/18 (2006.01) A61K 31/702 (2006.01) A61K 31/7042 (2006.01) A61K 31/7048 (2006.01) A61K 31/7056 (2006.01) A61K 31/706 (2006.01) A61P 37/06 (2006.01) C07H 3/06 (2006.01)

Patent

CA 2546784

Compounds and methods are provided for modulating in vivo and in vivo processes mediated by selectin biniding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g. inhibit or enhance) a selectin-mediated function comprise particular glycomimetics linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids).

L'invention concerne des composés et des méthodes permettant de moduler des procédés in vivo et in vivo dont la médiation est assurée par la liaison à la sélectine. L'invention concerne plus particulièrement des modulateurs de sélectine et leur utilisation. Ces modulateurs qui modulent (c'est-à-dire, qui inhibent ou augmentent) une fonction dont la médiation est assurée par la sélectine comprennent des glycomimétiques particuliers reliés à un élément d'une classe de composés dénommés BASA (Benzyl Amino Sulfonic Acids).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycomimetic antagonists for both e- and p-selectins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycomimetic antagonists for both e- and p-selectins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycomimetic antagonists for both e- and p-selectins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1908811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.